Nu Skin Enterprises Inc. (NYSE:NUS) Relative Strength Index (RSI) is 40.15, with weekly volatility at 2.64% and ATR at 1.37. The NUS stock’s 52-week price range has touched low of $36.38 and a $63.85 high. Intraday shares traded counted 0.47 million, which was -9.09% lower than its 30-day average trading volume of 429.61K. Its shares traded lower over the last trading session, losing -2.61% on 06/17/21. The shares fell to a low of $56.595 before closing at $57.09. NUS’s previous close was $58.62 while the outstanding shares total 50.71M. The firm has a beta of 1.19, a 12-month trailing P/E ratio of 13.61, and a growth ratio of 2.00.
Investors have identified the Household & Personal Products company Nu Skin Enterprises Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $2.84 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Nu Skin Enterprises Inc. (NUS) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For NUS, the company has in raw cash 339.1 million on their books with 90.0 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 900.89 million total, with 561.58 million as their total liabilities.
NUS were able to record -38.23 million as free cash flow during the 08/05/2021 quarter of the year, this saw their quarterly net cash flow reduce by -63.58 million. In cash movements, the company had a total of -18.86 million as operating cash flow.
Potential earnings growth for Nu Skin Enterprises Inc. (NUS)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/05/2021 quarter of the year, Nu Skin Enterprises Inc. recorded a total of 677.03 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 23.48% coming in sequential stages and their sales for the 08/05/2021 quarter reducing by -10.51%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 170.57 million trying to sell their products during the last quarter, with the result yielding a gross income of 506.46 million. This allows shareholders to hold on to 50.71M with the recently reported earning now reading 0.94 cents per share. This is a figure that compared to analyst’s prediction for their 08/05/2021 (0.91 cents a share).
Having a look at the company’s valuation, the company is expected to record 4.47 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on NUS sounds very interesting.
Is the stock of NUS attractive?
In related news, General Counsel, DORNY D MATTHEW sold 6,200 shares of the company’s stock in a transaction that recorded on Jun 01. The sale was performed at an average price of 60.78, for a total value of 376,836. As the sale deal closes, the Chief Accounting Officer, Thomas James D now sold 10,619 shares of the company’s stock, valued at 637,140. Also, General Counsel, DORNY D MATTHEW sold 6,200 shares of the company’s stock in a deal that was recorded on May 11. The shares were price at an average price of 58.92 per share, with a total market value of 365,278. Following this completion of acquisition, the Chief Financial Officer, Lawrence Mark H now holds 500 shares of the company’s stock, valued at 27,500. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.40%.
2 out of 6 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Nu Skin Enterprises Inc.. 0 analysts has assigned a Sell rating on the NUS stock. The 12-month mean consensus price target for the company’s shares has been set at $66.00.